{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"LAVA Therapeutics N.V."},"Symbol":{"label":"Symbol","value":"LVTX"},"Address":{"label":"Address","value":"YALELAAN 60, UTRECHT, 3584 CM, Netherlands"},"Phone":{"label":"Phone","value":"+31 850163100"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells."},"CompanyUrl":{"label":"Company Url","value":"https://www.lavatherapeutics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Charles Q. Morris","title":"Chief Medical Officer"},{"name":"Hans van der Vliet","title":"Chief Scientific Officer"},{"name":"Jessica Truscello","title":"Vice President-Clinical Operations"},{"name":"Paul W. H. I. Parren","title":"MD, EVP, Head-Research & Development"},{"name":"Stephen Allen Hurly","title":"President, CEO, Executive Director & MD"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}